| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.6M | — | -91.7% |
| R&D Expense | $60.3M | — | -33.6% |
| SG&A Expense | $19.1M | — | -28.2% |
| Operating Income | -$63.8M | — | -189.4% |
| Pre-tax Income | -$57.5M | — | -169.2% |
| Income Tax | $100K | — | -50.0% |
| Net Income | -$57.6M | — | -169.5% |
| EPS (Basic) | -$0.90 | — | -178.9% |
| EPS (Diluted) | -$0.90 | — | -178.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $87.3M | -38.9% | +7.8% |
| Short-term Investments | $527.6M | -2.7% | -39.6% |
| Accounts Receivable | $1.8M | +80.0% | +350.0% |
| Current Assets | $630.7M | -10.0% | -35.6% |
| Total Assets | $647.5M | -9.8% | -35.3% |
| Current Liabilities | $115.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$69.2M | — | +22.2% |
| Capital Expenditures | $1.3M | — | +225.0% |
| Investing Cash Flow | $13.7M | — | -80.3% |
| Financing Cash Flow | -$100K | — | +0.0% |
| Free Cash Flow | -$70.5M | — | +21.1% |
| -45.8% |
| Long-term Debt | $500K | -16.7% | -28.6% |
| Total Liabilities | $260.7M | -8.2% | -23.5% |
| Stockholders' Equity | $386.8M | -10.9% | -41.4% |